Identification of CETP as a molecular target for estrogen positive breast cancer cell death by cholesterol depleting agents

Genes and Cancer

Volumn 7, Issue 9-10, 2016, Pages 309-322

  Esau, Luke ^a   Sagar, Sunil ^a   Bangarusamy, Dhinoth ^a   Kaur, Mandeep ^a,b  

^a KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Saudi Arabia)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Acetyl plumbagin; Breast cancer; CETP; Cholesterol depletion

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINEOPLASTIC AGENT; APOLIPOPROTEIN; ASPARTATE AMINOTRANSFERASE; CASPASE 3; CASPASE 7; CASPASE 9; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAMMALIAN TARGET OF RAPAMYCIN; PLUMBAGIN; PREGNANE X RECEPTOR; PROTEIN; S6 KINASE; TAMOXIFEN; TRANSCRIPTION FACTOR ELF 4; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CANCER RECURRENCE; CANCER SURVIVAL; CELL VIABILITY; CELLULAR THERMAL SHIFT ASSAY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENETIC PROCEDURES; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; MTT ASSAY; NONHUMAN; OVERALL SURVIVAL; OXIDATIVE PHOSPHORYLATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

EID: 85048256044     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.18632/genesandcancer.122     Document Type: Article

References (48)

1. Silvente-Poirot S and Poirot M. Cholesterol metabolism and cancer: the good, the bad and the ugly. Current opinion in pharmacology. 2012; 12(6):673-676.
2. Furberg AS, Jasienska G, Bjurstam N, Torjesen PA, Emaus A, Lipson SF, Ellison PT and Thune I. Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2005; 14(1):33-40.
3. Liu YL, Qian HX, Qin L, Zhou XJ and Zhang B. Serum LDL-C and LDL-C/HDL-C ratio are positively correlated to lymph node stages in males with colorectal cancer. Hepato-gastroenterology. 2011; 58(106):383-387.
4. Vilchez JA, Martinez-Ruiz A, Sancho-Rodriguez N, Martinez-Hernandez P and Noguera-Velasco JA. The real role of prediagnostic high-density lipoprotein cholesterol and the cancer risk: a concise review. European journal of clinical investigation. 2014; 44(1):103-114.
5. Clendening JW and Penn LZ. Targeting tumor cell metabolism with statins. Oncogene. 2012; 31(48):4967-4978.
6. Ginestier C, Monville F, Wicinski J, Cabaud O, Cervera N, Josselin E, Finetti P, Guille A, Larderet G, Viens P, Sebti S, Bertucci F, Birnbaum D and Charafe-Jauffret E. Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target. Stem cells (Dayton, Ohio). 2012; 30(7):1327-1337.
7. Mo H and Elson CE. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Experimental biology and medicine (Maywood, NJ). 2004; 229(7):567-585.
8. Babina IS, Donatello S, Nabi IR and Hopkins AM. Lipid rafts as master regulators of breast cancer cell function. 2011.
9. Li YC, Park MJ, Ye SK, Kim CW and Kim YN. Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents. The American journal of pathology. 2006; 168(4):1107-1118; quiz 1404-1105.
10. Dillard PR, Lin MF and Khan SA. Androgen-independent prostate cancer cells acquire the complete steroidogenic potential of synthesizing testosterone from cholesterol. Molecular and cellular endocrinology. 2008; 295(1-2):115-120.
11. Mostaghel EA, Solomon KR, Pelton K, Freeman MR and Montgomery RB. Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors. PloS one. 2012; 7(1):e30062.
12. Gorin A, Gabitova L and Astsaturov I. Regulation of cholesterol biosynthesis and cancer signaling. Current opinion in pharmacology. 2012; 12(6):710-716.
13. Llaverias G, Danilo C, Mercier I, Daumer K, Capozza F, Williams TM, Sotgia F, Lisanti MP and Frank PG. Role of cholesterol in the development and progression of breast cancer. The American journal of pathology. 2011; 178(1):402-412.
14. Nelson ER, Chang CY and McDonnell DP. Cholesterol and breast cancer pathophysiology. Trends in endocrinology and metabolism: TEM. 2014; 25(12):649-655.
15. Nelson ER, Wardell SE, Jasper JS, Park S, Suchindran S, Howe MK, Carver NJ, Pillai RV, Sullivan PM, Sondhi V, Umetani M, Geradts J and McDonnell DP. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Science (New York, NY). 2013; 342(6162):1094-1098.
16. Wu Q, Ishikawa T, Sirianni R, Tang H, McDonald JG, Yuhanna IS, Thompson B, Girard L, Mineo C, Brekken RA, Umetani M, Euhus DM, Xie Y and Shaul PW. 27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth. Cell reports. 2013; 5(3):637-645.
17. Mohammad N, Malvi P, Meena AS, Singh SV, Chaube B, Vannuruswamy G, Kulkarni MJ and Bhat MK. Cholesterol depletion by methyl-beta-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma. Molecular cancer. 2014; 13:204.
18. Silvente-Poirot S and Poirot M. Cholesterol and Cancer, in the Balance. Science (New York, NY). 2014; 343(6178):1445-1446.
19. Warita K, Warita T, Beckwitt CH, Schurdak ME, Vazquez A, Wells A and Oltvai ZN. Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion. Scientific reports. 2014; 4:7593.
20. Danilo C and Frank PG. Cholesterol and breast cancer development. Current opinion in pharmacology. 2012; 12(6):677-682.
21. dos Santos CR, Domingues G, Matias I, Matos J, Fonseca I, de Almeida JM and Dias S. LDL-cholesterol signaling induces breast cancer proliferation and invasion. Lipids in health and disease. 2014; 13:16.
22. Lagrost L. Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies. Biochimica et biophysica acta. 1994; 1215(3):209-236.
23. Cazita PM, Berti JA, Aoki C, Gidlund M, Harada LM, Nunes VS, Quintao EC and Oliveira HC. Cholesteryl ester transfer protein expression attenuates atherosclerosis in ovariectomized mice. Journal of lipid research. 2003; 44(1):33-40.
24. Cappel DA, Palmisano BT, Emfinger CH, Martinez MN, McGuinness OP and Stafford JM. Cholesteryl ester transfer protein protects against insulin resistance in obese female mice. Molecular metabolism. 2013; 2(4):457-467.
25. Izem L and Morton RE. Possible role for intracellular cholesteryl ester transfer protein in adipocyte lipid metabolism and storage. The Journal of biological chemistry. 2007; 282(30):21856-21865.
26. Tchoua U, D’Souza W, Mukhamedova N, Blum D, Niesor E, Mizrahi J, Maugeais C and Sviridov D. The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport. Cardiovascular research. 2008; 77(4):732-739.
27. Sagar S, Esau L, Moosa B, Khashab NM, Bajic VB and Kaur M. Cytotoxicity and apoptosis induced by a plumbagin derivative in estrogen positive MCF-7 breast cancer cells. Anti-cancer agents in medicinal chemistry. 2014; 14(1):170-180.
28. Checker R, Gambhir L, Sharma D, Kumar M and Sandur SK. Plumbagin induces apoptosis in lymphoma cells via oxidative stress mediated glutathionylation and inhibition of mitogen-activated protein kinase phosphatases (MKP1/2). Cancer letters. 2015; 357(1):265-278.
29. Eldhose B, Gunawan M, Rahman M, Latha MS and Notario V. Plumbagin reduces human colon cancer cell survival by inducing cell cycle arrest and mitochondria-mediated apoptosis. International journal of oncology. 2014; 45(5):1913-1920.
30. Xu KH and Lu DP. Plumbagin induces ROS-mediated apoptosis in human promyelocytic leukemia cells in vivo. Leukemia research. 2010; 34(5):658-665.
31. Zhou ZW, Li XX, He ZX, Pan ST, Yang Y, Zhang X, Chow K, Yang T, Qiu JX, Zhou Q, Tan J, Wang D and Zhou SF. Induction of apoptosis and autophagy via sirtuin1-and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer cells. Drug design, development and therapy. 2015; 9:1511-1554.
32. Kontush A and Chapman MJ. Antiatherogenic small, dense HDL--guardian angel of the arterial wall? Nature clinical practice Cardiovascular medicine. 2006; 3(3):144-153.
33. Le Goff W, Guerin M and Chapman MJ. Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia. Pharmacology & therapeutics. 2004; 101(1):17-38.
34. Richardson MA, Berg DT, Johnston PA, McClure D and Grinnell BW. Human liposarcoma cell line, SW872, secretes cholesteryl ester transfer protein in response to cholesterol. Journal of lipid research. 1996; 37(5):1162-1166.
35. Liu J, Xian G, Li M, Zhang Y, Yang M, Yu Y, Lv H, Xuan S, Lin Y and Gao L. Cholesterol oxidase from Bordetella species promotes irreversible cell apoptosis in lung adenocarcinoma by cholesterol oxidation. Cell death & disease. 2014; 5:e1372.
36. Granot E, Tabas I and Tall AR. Human plasma cholesteryl ester transfer protein enhances the transfer of cholesteryl ester from high density lipoproteins into cultured HepG2 cells. The Journal of biological chemistry. 1987; 262(8):3482-3487.
37. Sukkasem N, Chatuphonprasert W, Tatiya-Aphiradee N and Jarukamjorn K. Imbalance of the antioxidative system by plumbagin and Plumbago indica L. extract induces hepatotoxicity in mice. Journal of intercultural ethnopharmacology. 2016; 5(2):137-145.
38. Haddad SA, Lunetta KL, Ruiz-Narvaez EA, Bensen JT, Hong CC, Sucheston-Campbell LE, Yao S, Bandera EV, Rosenberg L, Haiman CA, Troester MA, Ambrosone CB and Palmer JR. Hormone-related pathways and risk of breast cancer subtypes in African American women. Breast cancer research and treatment. 2015; 154(1):145-154.
39. Shim JS, Li RJ, Lv J, Head SA, Yang EJ and Liu JO. Inhibition of angiogenesis by selective estrogen receptor modulators through blockade of cholesterol trafficking rather than estrogen receptor antagonism. Cancer letters. 2015; 362(1):106-115.
40. Lappano R, Recchia AG, De Francesco EM, Angelone T, Cerra MC, Picard D and Maggiolini M. The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor alpha-mediated signaling in cancer cells and in cardiomyocytes. PloS one. 2011; 6(1):e16631.
41. de Gonzalo-Calvo D, Lopez-Vilaro L, Nasarre L, Perez-Olabarria M, Vazquez T, Escuin D, Badimon L, Barnadas A, Lerma E and Llorente-Cortes V. Intratumor cholesteryl ester accumulation is associated with human breast cancer proliferation and aggressive potential: a molecular and clinicopathological study. BMC cancer. 2015; 15:460.
42. Kaiser J. Cancer. Cholesterol forges link between obesity and breast cancer. Science (New York, NY). 2013; 342(6162):1028.
43. Poirot M, Silvente-Poirot S and Weichselbaum RR. Cholesterol metabolism and resistance to tamoxifen. Current opinion in pharmacology. 2012; 12(6):683-689.
44. Rodrigues Dos Santos C, Fonseca I, Dias S and Mendes de Almeida JC. Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression. BMC cancer. 2014; 14:132.
45. Kaur M and Esau L. Two-step protocol for preparing adherent cells for high-throughput flow cytometry. BioTechniques. 2015; 59(3):119-126.
46. Jafari R, Almqvist H, Axelsson H, Ignatushchenko M, Lundback T, Nordlund P and Martinez Molina D. The cellular thermal shift assay for evaluating drug target interactions in cells. Nature protocols. 2014; 9(9):2100-2122.
47. Zhang JH, Chung TD and Oldenburg KR. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen. 1999; 4(2):67-73.
48. Goswami CP and Nakshatri H. PROGgene: gene expression based survival analysis web application for multiple cancers. Journal of Clinical Bioinformatics. 2013; 3(1):22.